ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 88 filers reported holding ADURO BIOTECH INC in Q3 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $45,000 | +221.4% | 3,080 | -42.1% | 0.00% | – |
| Q2 2020 | $14,000 | +40.0% | 5,318 | -38.1% | 0.00% | – |
| Q4 2019 | $10,000 | +66.7% | 8,598 | +49.6% | 0.00% | – |
| Q3 2019 | $6,000 | -33.3% | 5,747 | +3.6% | 0.00% | – |
| Q2 2019 | $9,000 | +50.0% | 5,547 | +256.3% | 0.00% | – |
| Q1 2019 | $6,000 | +200.0% | 1,557 | +72.4% | 0.00% | – |
| Q4 2018 | $2,000 | -33.3% | 903 | +103.8% | 0.00% | – |
| Q3 2018 | $3,000 | -50.0% | 443 | -53.5% | 0.00% | – |
| Q2 2018 | $6,000 | +20.0% | 952 | +91.9% | 0.00% | – |
| Q1 2018 | $5,000 | +25.0% | 496 | -6.6% | 0.00% | – |
| Q4 2017 | $4,000 | -60.0% | 531 | -40.9% | 0.00% | – |
| Q3 2017 | $10,000 | -23.1% | 899 | -22.2% | 0.00% | – |
| Q2 2017 | $13,000 | +62.5% | 1,156 | +50.5% | 0.00% | – |
| Q1 2017 | $8,000 | -46.7% | 768 | -39.7% | 0.00% | – |
| Q4 2016 | $15,000 | -11.8% | 1,274 | -7.0% | 0.00% | – |
| Q3 2016 | $17,000 | +112.5% | 1,370 | +101.2% | 0.00% | – |
| Q2 2016 | $8,000 | -92.8% | 681 | -92.2% | 0.00% | – |
| Q1 2016 | $111,000 | – | 8,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 640,595 | $4,708,000 | 1.20% |
| BVF INC/IL | 287,776 | $2,115,000 | 0.19% |
| ORACLE INVESTMENT MANAGEMENT INC | 111,542 | $820,000 | 0.18% |
| Sofinnova Investments, Inc. | 189,579 | $1,393,000 | 0.12% |
| CENTAURUS FINANCIAL, INC. | 85 | $624,000 | 0.11% |
| Artal Group S.A. | 550,000 | $4,043,000 | 0.10% |
| Vident Investment Advisory, LLC | 305,311 | $2,244,000 | 0.09% |
| Virtus ETF Advisers LLC | 61,463 | $452,000 | 0.05% |
| Foundry Partners, LLC | 106,907 | $786,000 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 239,301 | $1,759,000 | 0.02% |